SPDR S&P Biotech ETF
199 hedge funds and large institutions have $3.15B invested in SPDR S&P Biotech ETF in 2015 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 51 increasing their positions, 71 reducing their positions, and 29 closing their positions.
Holders
199
Holders Change
+3
Holders Change %
+1.53%
% of All Funds
5.23%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
37
Increased
51
Reduced
71
Closed
29
Calls
$490M
Puts
$1.2B
Net Calls
-$709M
Net Calls Change
+$110M
Top Buyers
| 1 |
1
BNP Paribas Financial Markets
Paris,
France
|
$208M |
| 2 |
2
Morgan Stanley
New York
|
$886M |
| 3 |
3
LPL Financial
San Diego,
California
|
$33.6M |
| 4 |
4
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$23.1M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$15.3M |
